| Mary Bartholomew, RN | |
|
314 E State St, Trenton, NJ 08608-1810 | |
| (609) 396-4258 | |
| (609) 393-4647 |
| Full Name | Mary Bartholomew |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Community Health |
| Location | 314 E State St, Trenton, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114198215 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WC1500X | Registered Nurse - Community Health | 26NR06457300 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mary Bartholomew, RN 314 E State St, Trenton, NJ 08608-1810 Ph: (609) 396-4258 | Mary Bartholomew, RN 314 E State St, Trenton, NJ 08608-1810 Ph: (609) 396-4258 |
News Archive
Researchers with UC Irvine's Chao Family Comprehensive Cancer Center have identified a major reason why melanoma is largely resistant to chemotherapy.
A new study found that treatment-resistant epilepsy (TRE) is common in idiopathic autism. Early age at the onset of seizures and delayed global development were associated with a higher frequency of resistance to antiepileptic drugs (AEDs). Full findings appear online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy (ILAE).
Two Kansas State University psychology researchers have found that although central vision allows our eyes to discern the details of a scene, our peripheral vision is most important for telling us what type of scene we're looking at in the first place, such as whether it is a street, a mountain or a kitchen.
Debiopharm Group™(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs including anti-infective and oncology therapeutics as well as companion diagnostics, today announced that the US Food and Drug Administration (FDA) has designated its anti-infectious agent Debio 1450 as a Qualified Infectious Disease Product (QIDP) for the treatment of acute bacterial skin and skin structure infections (ABSSSI).
Cardium Therapeutics, Inc. today reported it has closed its registered direct offering announced on March 9, 2010. The offering resulted in total gross proceeds to Cardium of $11.3 million, which included the full initial offering amount of $10.0 million, plus an additional overallotment amount purchased by institutional investors.
› Verified 7 days ago
Justine M Sponziello, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 601 Hamilton Ave, Trenton, NJ 08629 Phone: 609-599-5000 | |
Theresa Baker, CRNFA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 601 Hamilton Ave, Trenton, NJ 08629 Phone: 609-599-5000 | |
Bernice Jones, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 150 Estates Blvd Apt G105, Trenton, NJ 08610 Phone: 917-306-6417 | |
Mr. Kenneth R Wolski, RN, MPA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 219 Woodside Ave, Trenton, NJ 08618 Phone: 609-394-2137 | |
Phyllis Yuen Mak, RNFAG Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 750 Brunswick Ave, Trenton, NJ 08638 Phone: 908-917-1111 | |
Milo Haws, TMBT Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 225 E State St Ste 12, Trenton, NJ 08608 Phone: 609-695-8100 | |
Claire Corrielus, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 132 Perry St, Trenton, NJ 08618 Phone: 609-394-8988 Fax: 609-599-1561 |